It’s been another busy week on the coronavirus front in Europe, with both the UK and the EU authorizing the use of Moderna’s COVID-19 vaccine, and the UK giving the go-ahead for the off-label use of two monoclonal antibody drugs, RoActemra and Kevzara, in hospitalized patients.
The European Commission said it planned to double its orders of the Pfizer Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?